Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood

No abstract is available for this paper.

• Publication year

  2009

• Venue

  British Journal of Haematology

• Publication date

  2009-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2141.2009.07828.xPMID 19796274PMCID PMC2782564
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation.

  2009cited by this paper
• Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor.

  2008cited by this paper
• Current status of reduced-intensity allogeneic stem cell transplantation using alternative donors

  2008cited by this paper
• Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes.

  2008cited by this paper
• Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases

  2008cited by this paper
• Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival.

  2008cited by this paper
• Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome

  2008cited by this paper
• Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies.

  2008cited by this paper
• Unrelated Cord Blood Transplantation (UCBT) for Transfusion- Dependent Thalassemia a CIBMTR Audited Retrospective Analysis of 30 Consecutive Patients from a Single Center

  2008cited by this paper
• Emerging trends in transplantation of inherited metabolic diseases

  2008cited by this paper
• Effect of Stem Cell Source on Transplant Outcomes in Adults with Acute Leukemia: A Comparison of Unrelated Bone Marrow (BM), Peripheral Blood (PB) and Cord Blood (CB)

  2008cited by this paper
• Umbilical cord blood transplantation after reduced-intensity conditioning for elderly patients with hematologic diseases.

  2008cited by this paper
• Unrelated cord blood transplantation in children with sickle cell disease: Review of four‐center experience

  2007cited by this paper
• Matched‐related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research

  2007cited by this paper
• Expanding the role of umbilical cord blood transplantation

  2007cited by this paper
• Hematopoietic cell therapy for metabolic disease.

  2007cited by this paper
• Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia.

  2007cited by this paper
• Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study.

  2007cited by this paper
• Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival.

  2007cited by this paper
• Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.

  2007cited by this paper
• Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure

  2007cited by this paper
• Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen.

  2007cited by this paper
• Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation.

  2006cited by this paper
• Donor cell-derived acute myeloid leukemia after unrelated umbilical cord blood transplantation

  2006cited by this paper
• Cord blood transplantation.

  2006cited by this paper
• Cord blood donor cell leukemia in recipients

  2006cited by this paper
• Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases.

  2006cited by this paper
• Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen for advanced Hodgkin lymphoma.

  2006cited by this paper
• Double umbilical cord blood transplantation.

  2006cited by this paper
• Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation.

  2006cited by this paper
• Successful engraftment without radiation after fludarabine‐based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation

  2006cited by this paper
• Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months.

  2006cited by this paper
• Human leukocyte antigen matching in cord blood transplantation.

  2005cited by this paper
• Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT).

  2005cited by this paper
• Donor cell derived acute myeloid leukemia after allogeneic cord blood transplantation in a patient with adult T‐cell lymphoma

  2005cited by this paper
• First report of donor cell-derived acute leukemia as a complication of umbilical cord blood transplantation.

  2005cited by this paper
• Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen.

  2005cited by this paper
• Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience.

  2005cited by this paper
• Cord blood transplant in childhood ALL

  2005cited by this paper
• Reduced-intensity unrelated cord blood transplantation for patients with advanced malignant lymphoma.

  2005influential reference
• Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source.

  2005cited by this paper
• Risk of Relapse (REL) after Umbilical Cord Blood Transplantation (UCBT) in Patients with Acute Leukemia: Marked Reduction in Recipients of Two Units.

  2005cited by this paper
• Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice.

  2004cited by this paper
• A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients

  2004cited by this paper
• Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.

  2004cited by this paper
• Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children.

  2004influential reference
• Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies.

  2004influential reference
• Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.

  2004influential reference
• Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA‐matched unrelated donor allogeneic transplantation in adults

  2004cited by this paper
• Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease.

  2003cited by this paper
• Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning.

  2003cited by this paper
• Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation.

  2002cited by this paper
• Single‐centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched‐related and matched‐unrelated donor transplants

  2002cited by this paper
• Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.

  2002cited by this paper
• Unrelated marrow transplantation for children with acute lymphoblastic leukemia in second remission.

  2002cited by this paper
• [Cord blood transplantation].

  2002influential reference
• Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients.

  2001cited by this paper
• Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.

  2001cited by this paper
• Prospective monitoring of the Epstein–Barr virus DNA by a real‐time quantitative polymerase chain reaction after allogenic stem cell transplantation

  2001cited by this paper
• Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.

  2001cited by this paper
• Donor cell leukemia: Report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature

  2000cited by this paper
• Outcomes among 562 recipients of placental-blood transplants from unrelated donors.

  1998cited by this paper
• Unrelated donor bone marrow transplantation for children with acute leukemia.

  1997cited by this paper
• Outcome of cord-blood transplantation from related and unrelated donors

  1997cited by this paper
• Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group.

  1997cited by this paper
• Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients.

  1996cited by this paper
• Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease.

  1996cited by this paper
• The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation.

  1994cited by this paper
• Transplantation

  1963cited by this paper

• An efficient method for isolation and expansion of hematopoietic stem cells derived from human umbilical cord blood cells

  2025cites this paper
• Efficacy and Safety of Allogeneic Hematopoietic Stem Cell Transplantation in Curing Sickle Cell Disease: A Systematic Review and Meta-Analysis of Single-Arm Studies.

  2025cites this paper
• Hematopoietic stem cells: Understanding the mechanisms to unleash the therapeutic potential of hematopoietic stem cell transplantation

  2025cites this paper
• CYP2B6 genetic variation in cyclophosphamide metabolism and hemorrhagic cystitis in Fanconi anemia patients undergoing allogeneic hematopoietic cell transplantation: A descriptive genetic association study

  2025cites this paper
• [Update for cord blood unit selection in hematopoietic stem cell transplantation (workshop SFGM-TC)].

  2024cites this paper
• Umbilical Cord Blood Hematopoietic Cells: From Biology to Hematopoietic Transplants and Cellular Therapies.

  2024cites this paper
• Trends in allogeneic hematopoietic cell transplantation survival using population-based descriptive epidemiology method: analysis of national transplant registry data

  2024cites this paper
• The Ethical Challenges of Umbilical Cord Blood Stem Cell Banking: A Qualitative Study

  2024cites this paper
• The Evaluation of Mass/DNA Copy Number of Mitochondria in Umbilical Cord Blood-derived Hematopoietic Stem Cells Cocultured with MSCs

  2024cites this paper
• Development of an umbilical cord blood transplantation–specific nonrelapse mortality risk assessment score

  2024cites this paper
• Further biological characterization of small molecules UM171 and SR1: In vitro effects on three hematopoietic cell populations from human cord blood.

  2024cites this paper
• Novel Human Umbilical Di-Chimeric (HUDC) cell therapy for transplantation without life-long immunosuppression

  2023cites this paper
• Fresh Umbilical Cord Blood—A Source of Multipotent Stem Cells, Collection, Banking, Cryopreservation, and Ethical Concerns

  2023cites this paper
• Expanding the scope of the infectious diseases pharmacist in HCT: Beyond antimicrobial stewardship

  2023cites this paper
• New case of HIV cure: joined forces of haploidentical stem cells and HLA-mismatched cord blood

  2023cites this paper
• Umbilical Cord Blood Transplantation: Connecting Its Origin to Its Future

  2023cites this paper
• PLAG1 dampens protein synthesis to promote human hematopoietic stem cell self-renewal

  2022cites this paper
• Hematopoietik Kök Hücre Nakil Süreci

  2022cites this paper
• HLA-Haploidentical Family Donors: The New Promise for Childhood Acute Lymphoblastic Leukaemia?

  2022cites this paper
• Clinical Progress and Preclinical Insights Into Umbilical Cord Blood Transplantation Improvement

  2022cites this paper
• Investigation of human parvovirus B19 prevalence in a large healthy umbilical cord blood donors

  2022cites this paper
• Multimodal Tracking of Hematopoietic Stem Cells from Young and Old Mice Labeled with Magnetic–Fluorescent Nanoparticles and Their Grafting by Bioluminescence in a Bone Marrow Transplant Model

  2021cites this paper
• Stenotrophomonas maltophilia bloodstream infections in adult recipients of umbilical cord blood transplantation.

  2021cites this paper
• Tissue Engineering in Wound Healing Therapy by Using Chitosan and Stem Cells

  2021cites this paper
• COVID-19 Pandemic Impact on Cord Blood Collection for Stem Cell Use and Actual Perspectives.

  2021cites this paper
• Comparison of clinical outcomes between unrelated single umbilical cord blood and “ex-vivo” T-cell depleted haploidentical transplantation in children with hematological malignancies

  2021cites this paper
• Inflammatory monocytes promote pre-engraftment syndrome and tocilizumab can therapeutically limit pathology in patients

  2021cites this paper
• Umbilical Cord Blood Transplants: Current Status and Evolving Therapies

  2020cites this paper
• Meta-analysis of hematopoietic stem cell transplantation in major histocompatibility complex class II deficiency.

  2020cites this paper
• Mesenchymal Stem Cells and Cardiovascular Diseases

  2020cites this paper
• Natural estrogens enhance the engraftment of human hematopoietic stem and progenitor cells in immunodeficient mice

  2020cites this paper
• Haploidentical Hematopoietic Stem Cell Transplantation Followed by ‘Post-Cyclophosphamide’: The Future of Allogeneic Stem Cell Transplant

  2020cites this paper
• Cord Blood Banking and Transplantation at the Mexican Institute of Social Security: Thirteen Years of Experience.

  2020cites this paper
• The benefit of exercise in patients who undergo allogeneic hematopoietic stem cell transplantation

  2019cites this paper
• Modern Ways of Obtaining Stem Cells

  2019cites this paper
• Cord blood 2.0: state of the art and future directions in transplant medicine

  2019cites this paper
• Serological and molecular screening of umbilical cord blood for Toxoplasma gondii infection

  2019cites this paper
• Optimizing cord blood selection.

  2019cites this paper
• Cell-based therapy for idiopathic pulmonary fibrosis.

  2019cites this paper
• Cord blood research, banking, and transplantation: achievements, challenges, and perspectives

  2019cites this paper
• Potentiel thérapeutique des progeniteurs endothéliaux dans le traitement de la défaillance ventriculaire droite secondaire à l'hypertension pulmonaire

  2019cites this paper
• Human Hematopoietic Stem Cells: Concepts and Perspectives on the Biology and Use of Fresh Versus In Vitro–Generated Cells for Therapeutic Applications

  2019cites this paper
• Factors Influencing the Umbilical Cord Blood Stem Cell Industry: An Evolving Treatment Landscape

  2018cites this paper
• Analysis of the Spanish CCR5-∆32 inventory of cord blood units: lower cell counts in homozygous donors

  2018cites this paper
• Mechanistic effects of mesenchymal and hematopoietic stem cells: New therapeutic targets in myocardial infarction

  2018cites this paper
• Stem cell therapy targeting the right ventricle in pulmonary arterial hypertension: is it a potential avenue of therapy?

  2018cites this paper
• 3-Dimensional nano-fibre scaffold for ex vivo expansion of cord blood haematopoietic stem cells

  2018cites this paper
• Impact of C-rel inhibition of cord blood-derived B-, T-, and NK cells

  2017cites this paper
• Immobilisation of Delta-like 1 ligand for the scalable and controlled manufacture of hematopoietic progenitor cells in a stirred bioreactor

  2017cites this paper
• CCR5-edited gene therapies for HIV cure: Closing the door to viral entry.

  2017cites this paper
• Overview of Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies.

  2017cites this paper
• Mesenchymal stem cell therapy: A promising cell‐based therapy for treatment of myocardial infarction

  2017cites this paper
• Optimization of Unrelated Donor Cord Blood Transplantation for Thalassemia: Implications for Other Non‐Malignant Indications such as HIV Infection or Autoimmune Diseases

  2017cites this paper
• Protective Role of Angiogenin Against Hematopoietic Syndrome of the Acute Radiation Syndrome

  2016influential citation
• Collection of umbilical cord blood for banking: collection rate and factors influencing collection.

  2016cites this paper
• Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft.

  2016cites this paper
• Alternative donors: cord blood for adults.

  2016cites this paper
• Cell-based therapies for the treatment of idiopathic pulmonary fibrosis (IPF) disease

  2016cites this paper
• Investing in Regenerative Medicine: What Drives Private Investors?

  2016cites this paper
• Injection of Human Cord Blood Cells With Hyaluronan Improves Postinfarction Cardiac Repair in Pigs

  2016cites this paper
• Human Stem Cells Overexpressing miR‐21 Promote Angiogenesis in Critical Limb Ischemia by Targeting CHIP to Enhance HIF‐1α Activity

  2016cites this paper
• Angiogenin Promotes Hematopoietic Regeneration by Dichotomously Regulating Quiescence of Stem and Progenitor Cells.

  2016cites this paper
• Impact of Graft-Recipient ABO Compatibility on Outcomes after Umbilical Cord Blood Transplant for Nonmalignant Disease.

  2016cites this paper
• Umbilical Cord Blood Transplantation

  2015cites this paper
• Umbilical cord blood graft engineering: challenges and opportunities

  2015cites this paper
• Immunogenetic factors in the selection of cord blood units for transplantation: current search strategies and future perspectives.

  2015cites this paper
• Mitochondrial superoxide reduction and cytokine secretion skewing by carbon nanotube scaffolds enhance ex vivo expansion of human cord blood hematopoietic progenitors.

  2015cites this paper
• Quantification of viral genome in cord blood donors by real time PCR to investigate human herpesvirus type 8 active infection.

  2015cites this paper
• Stem Cells and Cloning: Advances and Applications Progress toward curing Hiv infection with hematopoietic cell transplantation

  2015cites this paper
• Progress toward curing HIV infection with hematopoietic cell transplantation

  2015cites this paper
• Unrelated hematopoietic stem cell transplantation in the pediatric population: single institution experience

  2015cites this paper
• Stem Cells and Cloning: Advances and Applications

  2015cites this paper
• Impact of maternal and neonatal factors on parameters of hematopoietic potential in umbilical cord blood

  2015cites this paper
• Advancing lentiviral gene therapy vectors for β-thalassaemia

  2015cites this paper
• HIV and Stem Cell Transplantation

  2014cites this paper
• One-unit versus two-unit cord-blood transplantation for hematologic cancers.

  2014cites this paper
• Long-term outcome and prognostic factors of unrelated cord blood transplantation in children with haematological malignancies: a retrospective study using the Spanish Working Party for BMT in Children (GETMON) database

  2014cites this paper
• HIVand Stem Cell Transplantation

  2014cites this paper
• Unique Effects of Mycophenolate Mofetil on Cord Blood T Cells: Implications for GVHD Prophylaxis

  2014cites this paper
• Hematopoetic stem cell transplantation in children.

  2014cites this paper
• Stem Cell Biobanks and Long-Term Sustainability: A Swiss Working Model

  2014cites this paper
• Disease Specific Analysis of Cord Blood Transplantation for Adults and Clinical Results of Single and Double Umbilical Cord Blood Transplantation

  2014cites this paper
• Umbilical Cord Blood: Medical Waste or Important Source of Stem Cells?

  2013cites this paper
• Alternative Sources of Hematopoietic Stem Cells and Their Clinical Applications

  2013cites this paper
• Human Umbilical Cord Blood for Transplantation Therapy in Myocardial

  2013cites this paper
• Case report Combined umbilical cord blood and bone marrow transplantation from a sibling in a patient with Fanconi anemia

  2013cites this paper
• Mesenchymal Stem Cells and Haematopoietic Stem Cell Culture

  2013cites this paper
• Defining Regulators of Human Hematopoietic Stem Cells

  2013cites this paper
• Regulation of human hematopoietic stem cell lineage commitment

  2013cites this paper
• Razones para un banco de sangre de cordón umbilical en el Instituto de Hematología e Inmunología de Cuba

  2013cites this paper
• клеток пуповинной крови: возможности и перспективы для лечения пациентов с ВИЧ-инфекцией

  2013cites this paper
• US public cord blood banking practices: recruitment, donation, and the timing of consent

  2013cites this paper
• Cord blood transplantation for the treatment of acute leukemia.

  2013cites this paper
• Engraftment Outcomes after HPC Co-Culture with Mesenchymal Stromal Cells and Osteoblasts

  2013cites this paper
• Hematopoietic cell transplantation with cord blood for cure of HIV infections.

  2013cites this paper
• Human Umbilical Cord Blood for Transplantation Therapy in Myocardial Infarction.

  2013cites this paper
• Cell banks: Life blood

  2013cites this paper
• Analysis of 120 pediatric patients with nonmalignant disorders transplanted using unrelated plasma‐depleted or ‐reduced cord blood

  2012cites this paper
• Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen

  2012cites this paper
• Células progenitoras hematopoyéticas de sangre de cordón umbilical

  2012cites this paper